Analysed 60 DEGREES PHARMA INC (SXTP:NASDAQ) News Sources
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
15-04-2026
yahoo.com
60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should Know
03-04-2026
yahoo.com
Infrastructure Capital and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
02-04-2026
yahoo.com
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
02-04-2026
yahoo.com
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract
18-03-2026
yahoo.com
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
11-03-2026
yahoo.com
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
27-02-2026
yahoo.com
60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA
24-02-2026
yahoo.com
What is the current price of 60 DEGREES PHARMA INC (SXTP:NASDAQ)?
The current price of 60 DEGREES PHARMA INC (SXTP:NASDAQ) is $1.96.
60 DEGREES PHARMA INC (SXTP:NASDAQ) absolute price change since previous trading day?
The absolute price change of 60 DEGREES PHARMA INC (SXTP:NASDAQ) since the previous trading day is $-0.26.
60 DEGREES PHARMA INC (SXTP:NASDAQ) percentage price change since previous trading day?
The percentage price change of 60 DEGREES PHARMA INC (SXTP:NASDAQ) since the previous trading day is -11.7117%.
What is the most recent average sentiment score for 60 DEGREES PHARMA INC (SXTP:NASDAQ)?
The most recent average sentiment score for 60 DEGREES PHARMA INC (SXTP:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for 60 DEGREES PHARMA INC (SXTP:NASDAQ)?
The most recent sentiment for 60 DEGREES PHARMA INC (SXTP:NASDAQ) is .
SEC-8K** Filing Available For 60 DEGREES PHARMA INC (SXTP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.